This United States Securities and Exchange Commission (the “Commission”) Fair Fund is on behalf of investors who purchased or otherwise acquired Surgalign Holdings, Inc. (“Surgalign”) (now OTC: SRGAQ; formerly NASDAQ:SRGA) (f/k/a RTI Surgical Holdings, Inc. and RTI Surgical, Inc.) common stock between April 23, 2015 and March 16, 2020, inclusive (the “Relevant Period”).
Surgalign was ordered to pay $2,075,000 in civil penalties to compensate investors who were harmed by the company’s violations of federal securities laws.
What’s the status of the Settlement?
On March 31, 2025, the Commission approved the Plan of Distribution. The Fund Administrator has extended the claim filing deadline to February 23, 2026. The claim filing website is active and open for claims.
Who can file a claim?
The Fair Fund class includes all persons or entities who:
- Purchased or otherwise acquired Surgalign common stock between April 23, 2015 and March 16, 2020, inclusive.
How are the Fair Fund payments allocated?
Pro rata payment: The total Fair Fund is $2,075,000. The amount each investor receives will depend on several factors, including:
- The number of valid claims submitted
- The number of shares purchased and sold
- The dates of purchase and sale
- The price paid for the shares and the price received upon sale
How do I file a claim?
The deadline to file a claim is February 23, 2026. To submit a claim and/or to find additional information regarding the terms of the Fair Fund and claim filing process, go to www.surgalignholdingsfairfund.com, or contact the claims administrator, Epiq Class Action & Claims Solutions, Inc., at 1-877-629-4892.
If you wish to discuss this action or have any questions, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at info@ktmc.com.